Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.16% | 19.80% | 23.74% | 26.18% | 28.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.16% | 19.80% | 23.74% | 26.18% | 28.99% |
| Cost of Revenue | 237.80% | -38.82% | 22.94% | 37.07% | -99.33% |
| Gross Profit | 32.44% | 31.24% | 25.20% | 6.44% | 293.13% |
| SG&A Expenses | 2.32% | 2.11% | 0.18% | 10.36% | 20.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -2,112.37% | -- | -- | -- |
| Total Operating Expenses | 0.52% | -3.02% | 12.35% | 24.35% | 39.85% |
| Operating Income | 86.35% | 92.19% | 39.89% | -16.43% | -80.25% |
| Income Before Tax | 125.27% | 3.20% | 733.52% | 39.78% | -25.70% |
| Income Tax Expenses | 197.20% | 82.24% | -1,410.29% | 678.01% | 21.84% |
| Earnings from Continuing Operations | 120.56% | -20.48% | 864.24% | 31.73% | -25.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 120.56% | -20.48% | 864.24% | 31.73% | -25.64% |
| EBIT | 86.35% | 92.19% | 39.89% | -16.43% | -80.25% |
| EBITDA | 89.16% | 98.61% | 42.86% | -18.05% | -85.38% |
| EPS Basic | 120.47% | -19.26% | 848.91% | 33.51% | -21.38% |
| Normalized Basic EPS | 102.55% | 19.04% | 718.28% | 41.36% | -21.41% |
| EPS Diluted | 120.41% | -19.08% | 823.91% | 33.51% | -21.41% |
| Normalized Diluted EPS | 102.45% | 19.04% | 758.33% | 41.36% | -21.41% |
| Average Basic Shares Outstanding | 0.42% | 1.04% | 1.81% | 2.71% | 3.51% |
| Average Diluted Shares Outstanding | 4.16% | 1.04% | -2.49% | 2.71% | 3.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |